Literature DB >> 22370587

Time course of expiratory propofol after bolus injection as measured by ion molecule reaction mass spectrometry.

Cyrill Hornuss1, Dirk Wiepcke, Siegfried Praun, Michael E Dolch, Christian C Apfel, Gustav Schelling.   

Abstract

Propofol in exhaled breath can be detected and monitored in real time by ion molecule reaction mass spectrometry (IMR-MS). In addition, propofol concentration in exhaled breath is tightly correlated with propofol concentration in plasma. Therefore, real-time monitoring of expiratory propofol could be useful for titrating intravenous anesthesia, but only if concentration changes in plasma can be determined in exhaled breath without significant delay. To evaluate the utility of IMR-MS during non-steady-state conditions, we measured the time course of both expiratory propofol concentration and the processed electroencephalography (EEG) as a surrogate outcome for propofol effect after an IV bolus induction of propofol. Twenty-one patients scheduled for routine surgery were observed after a bolus of 2.5 mg kg(-1) propofol for induction of anesthesia. Expiratory propofol was measured using IMR-MS and the cerebral propofol effect was estimated using the bispectral index (BIS). Primary endpoints were time to detection of expiratory propofol and time to onset of propofol's effect on BIS, and the secondary endpoint was time to peak effect (highest expiratory propofol or lowest BIS). Expiratory propofol and changes in BIS were first detected at 43 ± 21 and 49 ± 11 s after bolus injection, respectively (P = 0.29). Peak propofol concentrations (9.2 ± 2.4 parts-per-billion) and lowest BIS values (23 ± 4) were reached after 208 ± 57 and 219 ± 62 s, respectively (P = 0.57). Expiratory propofol concentrations measured by IMR-MS have similar times to detection and peak concentrations compared with propofol effect as measured by the processed EEG (BIS). This suggests that expiratory propofol concentrations may be useful for titrating intravenous anesthesia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370587     DOI: 10.1007/s00216-012-5856-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  5 in total

Review 1.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

2.  Propofol Breath Monitoring as a Potential Tool to Improve the Prediction of Intraoperative Plasma Concentrations.

Authors:  Pieter Colin; Douglas J Eleveld; Johannes P van den Berg; Hugo E M Vereecke; Michel M R F Struys; Gustav Schelling; Christian C Apfel; Cyrill Hornuss
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

3.  Determination of breath isoprene allows the identification of the expiratory fraction of the propofol breath signal during real-time propofol breath monitoring.

Authors:  Cyrill Hornuss; Michael E Dolch; Silke Janitza; Kimberly Souza; Siegfried Praun; Christian C Apfel; Gustav Schelling
Journal:  J Clin Monit Comput       Date:  2013-03-23       Impact factor: 2.502

4.  Online exhaled propofol monitoring in normal-weight and obese surgical patients.

Authors:  Martin R Braathen; Ivan Rimstad; Terje Dybvik; Ståle Nygård; Johan Raeder
Journal:  Acta Anaesthesiol Scand       Date:  2022-02-19       Impact factor: 2.274

5.  Gram-negative and -positive bacteria differentiation in blood culture samples by headspace volatile compound analysis.

Authors:  Michael E Dolch; Silke Janitza; Anne-Laure Boulesteix; Carola Graßmann-Lichtenauer; Siegfried Praun; Wolfgang Denzer; Gustav Schelling; Sören Schubert
Journal:  J Biol Res (Thessalon)       Date:  2016-03-12       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.